Evidence map›Paper›PMID 42299154›Full record

ArticleJAMIA open2026

Benchmarking reliability and calibration of LLMs for multi-cancer early detection test communication.

Koki Takabatake, Maria Sol Rosito, Danielle Braun, Catherine Marinac, Elizabeth O'Donnell, Giovanni Parmigiani

Abstract read
In one paragraph

Article in JAMIA open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Koki TakabatakeBoston University Chobanian and Avedisian School of Medicine, Boston, MA, 02118, United States.
Maria Sol RositoDepartment of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, 02215, United States.
Danielle BraunDepartment of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, 02215, United States.ORCID https://orcid.org/0000-0002-5177-8598
Catherine MarinacDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States.
Elizabeth O'DonnellDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States.
Giovanni ParmigianiDepartment of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, 02215, United States.ORCID https://orcid.org/0000-0002-8783-5961

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To assess the reliability and confidence calibration of Large Language Models (LLMs) when communicating multi-cancer early detection (MCED) test characteristics in an expert-informed clinical evaluation. Materials and Methods: We curated 19 papers regarding prominent MCED tests and trials. Using Google's NotebookLM, we generated a question set that two MCED experts reviewed and finalized, comprising 94 multiple-choice questions (MCQs) and 13 free-response questions (FRQs). Five LLMs (ChatGPT, Claude, Gemini, Perplexity, OpenEvidence) each completed the question set three times. All models except OpenEvidence reported a confidence score (1-100) for every answer. We evaluated mean MCQ, FRQ, and overall accuracy. Confidence calibration for MCQs was assessed using reliability plots, Brier scores, and two high-confidence error metrics: proportion of answers with confidence ≥80 that were incorrect and proportion of incorrect answers with confidence ≥80. Between-model MCQ comparisons used Cochran's Q and post hoc McNemar tests; FRQ comparisons used Friedman test. Results: All models demonstrated high overall accuracy. Gemini achieved the highest performance (96.5% MCQ, 96% FRQ, 96.3% overall), though comparisons involving Gemini should be interpreted cautiously as it was evaluated under different time and blinding conditions. MCQ performance differed significantly across models, while FRQ performance did not. Most errors involved recalling precise numerical estimates. Despite low Brier scores across models, several models made high-confidence errors. Discussion: Subdomain and calibration analyses revealed systematic weaknesses in numerical recall and confidence reliability despite strong accuracy. Conclusion: LLMs may support communication of MCED information, but clinical use should incorporate verification workflows and human oversight.

Indexed as

cancer screeningearly detection of cancerLarge language modelsmedical informaticsnatural language processing

Identifiers

PMID42299154
PMCPMC13264670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.